ViiV Healthcare has initiated a rolling submission of a new drug application (NDA) with the US Food and Drug Administration (FDA) for investigational, long-acting, injectable cabotegravir (pre-exposure prophylaxis, or...

View the Online Magazine

- Advertisement -

Launches

Beckman Coulter launch workflow automation for mid-volume labs

Beckman Coulter, a clinical diagnostics leader, has announced the European launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized...

Newly launched British biotech pioneers ground-breaking potential treatments for COVID-19

A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and...

ACG launches ACGcaps™ NTone and ACGcaps™ TSafe Capsules

ACGcaps™ NTone is a portfolio of naturally coloured capsules and with no e-number. The aesthetically appealing colour solutions include Ocean Blue, Sunny Yellow, Desert...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Pfizer & BioNTech to supply EU with 100m additional comirnaty doses

Pfizer and BioNTech will supply an additional 100 million doses of comirnaty, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states...

UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is ‘safe and effective’

The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) reaffirmed the  benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh...

Clinigen signs Africa and Asia distribution agreement with Amgen

Clinigen Group, the global pharmaceutical Products and Services company, has signed a distribution agreement with Amgen to supply part of its product portfolio to...

New full-service packing design agency launched from state-of-the-art R&D facility in East Yorkshire

A new full-service packaging design, innovation and development agency, Design Innovation Development (DiD), has been launched for pharmaceutical and healthcare businesses, building on nearly...

Approvals

ViiV initiates rolling submission of NDA for injectable PrEP in US

ViiV Healthcare has initiated a rolling submission of a new drug application (NDA) with the US Food and Drug Administration (FDA) for investigational, long-acting,...

Farxiga approved in the US for the treatment of chronic kidney disease

AstraZeneca’s Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of sustained estimated glomerular filtration...

Manufacturiung

Finance

Research & Development
Latest

NIH scientists identify small-molecule cocktail to improve stem cell use

Researchers at the National Institutes of Health (NIH) have devised a four-part small-molecule cocktail that can protect stem cells called induced pluripotent stem cells...

FDA expands collaboration with CN Bio to investigate lung-on-a-chip model for inhaled drug evaluation applications

CN Bio, a developer of single- and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, has announced the U.S....

Vertex and Obsidian to discover novel therapies that regulate gene editing

Vertex Pharmaceuticals and Obsidian Therapeutics have entered into a strategic research collaboration and licensing agreement focused on the discovery of novel therapies that regulate...

Clinical trial to test therapeutics for hospitalised COVID-19 patients begins

A new Phase 3 trial to test the safety and efficacy of therapeutics for COVID-19 has begun enrolling patients hospitalized with life-threatening cases of...

Biogen and Bio-Thera Solutions to develop Actemra biosimilar

Biogen and Bio-Thera Solutions have entered into a commercialisation and license agreement to develop, manufacture and commercialise BAT1806, a Phase 3 clinical stage anti-interleukin-6...

Appointments

- Advertisement -